Atlas Trials

In-patient COVID-19 Study of Intranasal Foralumab

Clinical trial NCT04983446 · WITHDRAWN

Trial details

NCT number
NCT04983446
Sponsor
Tiziana Life Sciences LTD
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19COVID-19 Lower Respiratory InfectionCOVID-19 Respiratory Infection
Start date
2022-04-30
Primary completion
2022-10-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.